KCM

Kingdon Capital Management Portfolio holdings

AUM $976M Turnover 59%
1-Year Est. Return 66.76%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$933M
AUM Growth
+$17.2M
Cap. Flow
-$116M
Cap. Flow %
-12.39%
Top 10 Hldgs %
32.72%
Holding
112
New
29
Increased
12
Reduced
26
Closed
30
Avg Time Held Equity + Options
0.8 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
1 year
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.5 years

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.5M
2
AMD icon
Advanced Micro Devices
AMD
+$18.5M
3
INSP icon
Inspire Medical Systems
INSP
+$16.3M
4
CRL icon
Charles River Laboratories
CRL
+$15.8M
5
GH icon
Guardant Health
GH
+$15.6M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$20.8M
2
HUM icon
Humana
HUM
+$20.5M
3
THC icon
Tenet Healthcare
THC
+$16.9M
4
GE icon
GE Aerospace
GE
+$13.2M
5
ARMK icon
Aramark
ARMK
+$13M

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.58%
2 Healthcare 24.32%
3 Industrials 16.59%
4 Technology 10.07%
5 Consumer Staples 5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RSP icon
1
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$96.9B
$72.3M 7.75%
+440,000
New +$72.4M
2024 Q2
0 quarters
INSM icon
2
Insmed
INSM
$21.4B
$41.9M 4.49%
625,000
+170,000
+37% +$6.59M
2023 Q4
2 quarters
XLF icon
3
PUT
State Street Financial Select Sector SPDR ETF
XLF
$50.7B
$32.9M 3.53%
800,000
+50,000
+7% +$2.06M
2024 Q1
1 quarter
V icon
4
CALL
Visa
V
$735B
$26.2M 2.81%
+100,000
New +$27.4M
2024 Q2
0 quarters
FTAI icon
5
FTAI Aviation
FTAI
$16.8B
$24.8M 2.66%
240,000
-160,000
-40% -$12.7M
2023 Q1
5 quarters
APG icon
6
APi Group
APG
$17.3B
$23.5M 2.52%
937,500
-36,236
-4% -$910K
2020 Q2
16 quarters
BAC icon
7
CALL
Bank of America
BAC
$359B
$21.9M 2.34%
+550,000
New +$21.1M
2024 Q2
0 quarters
EEM icon
8
CALL
iShares MSCI Emerging Markets ETF
EEM
$29.8B
$21.3M 2.28%
500,000
+300,000
+150% +$12.6M
2023 Q4
2 quarters
IWM icon
9
PUT
iShares Russell 2000 ETF
IWM
$76.4B
$20.3M 2.17%
+100,000
New +$20.2M
2024 Q2
0 quarters
UNH icon
10
UnitedHealth
UNH
$355B
$20.2M 2.17%
+39,700
New +$19.5M
2024 Q2
0 quarters
GH icon
11
Guardant Health
GH
$21.9B
$19.4M 2.07%
+670,200
New +$15.6M
2024 Q2
0 quarters
AMD icon
12
Advanced Micro Devices
AMD
$932B
$18.7M 2%
+115,000
New +$18.5M
2024 Q2
0 quarters
THC icon
13
Tenet Healthcare
THC
$21.9B
$18.4M 1.97%
138,348
-140,352
-50% -$16.9M
2023 Q4
2 quarters
SNDX icon
14
Syndax Pharmaceuticals
SNDX
$1.21B
$18.4M 1.97%
894,993
– –
2023 Q4
2 quarters
PRAX icon
15
Praxis Precision Medicines
PRAX
$6.67B
$17.2M 1.84%
415,000
+65,000
+19% +$3.07M
2021 Q2
12 quarters
SMH icon
16
PUT
VanEck Semiconductor ETF
SMH
$68.8B
$16.9M 1.82%
65,000
-20,500
-24% -$4.81M
2024 Q1
1 quarter
XHB icon
17
PUT
State Street SPDR S&P Homebuilders ETF
XHB
$1.44B
$15.2M 1.63%
+150,000
New +$15.7M
2024 Q2
0 quarters
CRH icon
18
CRH
CRH
$52.7B
$15M 1.61%
200,000
+45,000
+29% +$3.59M
2024 Q1
1 quarter
TNDM icon
19
Tandem Diabetes Care
TNDM
$1.11B
$14.9M 1.59%
369,000
-124,080
-25% -$5.18M
2023 Q4
2 quarters
TAP icon
20
Molson Coors Class B
TAP
$7.2B
$14.6M 1.57%
288,200
– –
2023 Q1
5 quarters
CYTK icon
21
Cytokinetics
CYTK
$8.82B
$14.4M 1.55%
266,700
+150,700
+130% +$9.1M
2024 Q1
1 quarter
CRL icon
22
Charles River Laboratories
CRL
$14.4B
$14.4M 1.55%
+69,800
New +$15.8M
2024 Q2
0 quarters
PWR icon
23
Quanta Services
PWR
$99.3B
$14M 1.5%
55,000
+20,412
+59% +$5.41M
2022 Q4
6 quarters
META icon
24
Meta Platforms (Facebook)
META
$1.88T
$13.9M 1.49%
27,500
-12,500
-31% -$6.08M
2023 Q1
5 quarters
TSM icon
25
TSMC
TSM
$2.23T
$13.5M 1.44%
77,500
-2,500
-3% -$379K
2024 Q1
1 quarter
1
2 3 4 5

Similar funds

PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
ACM
Arini Captial Management London, United Kingdom $975M AUM
FM
Family Management New York $975M AUM 23.16% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $979M AUM 50.58% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
ZI
ZEGA Investments Palm Beach Gardens, Florida $973M AUM 27.27% 1-Year Est. Return
RIA
RPG Investment Advisory Pleasanton, California $973M AUM 39.93% 1-Year Est. Return
PC
Permanens Capital New York $972M AUM 27.73% 1-Year Est. Return

Kingdon Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Kingdon Capital Management held 112 positions worth $933M, up 1.9% from $916M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Kingdon Capital Management withdrew a net $116M in Q2 2024, closing 30 positions and reducing 26 holdings. Its most notable exit was Sherwin-Williams, an estimated $20.8M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Kingdon Capital Management opened a new position in UnitedHealth worth $20.2M.

  • Kingdon Capital Management's largest Q2 2024 buy was UnitedHealth: 39,700 shares worth $20.2M.
  • Kingdon Capital Management added most to Cytokinetics in Q2 2024, an estimated $9.1M increase.
  • Kingdon Capital Management's biggest Q2 2024 reduction was Tenet Healthcare, cutting an estimated $16.9M.
  • Kingdon Capital Management fully exited Sherwin-Williams in Q2 2024, selling an estimated $20.8M.
  • Kingdon Capital Management's ten largest holdings make up 33% of its $933M portfolio in Q2 2024.
  • Kingdon Capital Management opened 29 new positions and closed 30 in Q2 2024.
  • Kingdon Capital Management's portfolio value rose 1.9% quarter-over-quarter to $933M.

Based on Kingdon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.